Zhejiang HISUN Biomaterials Co. Ltd. A (688203) - Total Liabilities
Based on the latest financial reports, Zhejiang HISUN Biomaterials Co. Ltd. A (688203) has total liabilities worth CN¥542.63 Million CNY (≈ $79.40 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 688203 net assets growth trend to track the company's year-over-year net asset growth rate.
Zhejiang HISUN Biomaterials Co. Ltd. A - Total Liabilities Trend (2020–2024)
This chart illustrates how Zhejiang HISUN Biomaterials Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Zhejiang HISUN Biomaterials Co. Ltd. A to measure how efficiently the company converts operating cash flow to free cash.
Zhejiang HISUN Biomaterials Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Zhejiang HISUN Biomaterials Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
New Power Plasma Co.Ltd
KQ:144960
|
Korea | ₩567.46 Billion |
|
Idun Industrier AB Series B
ST:IDUN-B
|
Sweden | Skr1.47 Billion |
|
Guangxi Hechi Chemical Co Ltd
SHE:000953
|
China | CN¥100.06 Million |
|
Alpine Income Property Trust, Inc.
NYSE:PINE
|
USA | $414.62 Million |
|
International CSRC Investment Holdings Co Ltd
TW:2104
|
Taiwan | NT$22.94 Billion |
|
Sword Group S.E
PA:SWP
|
France | €227.23 Million |
|
Biofarm Bucure
RO:BIO
|
Romania | RON85.86 Million |
|
Andfjord Salmon AS
OL:ANDF
|
Norway | Nkr2.39 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down Zhejiang HISUN Biomaterials Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688203 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang HISUN Biomaterials Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang HISUN Biomaterials Co. Ltd. A (2020–2024)
The table below shows the annual total liabilities of Zhejiang HISUN Biomaterials Co. Ltd. A from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥574.05 Million ≈ $84.00 Million |
+0.84% |
| 2023-12-31 | CN¥569.25 Million ≈ $83.30 Million |
+19.45% |
| 2022-12-31 | CN¥476.56 Million ≈ $69.74 Million |
-9.96% |
| 2021-12-31 | CN¥529.26 Million ≈ $77.45 Million |
-4.70% |
| 2020-12-31 | CN¥555.36 Million ≈ $81.27 Million |
-- |
About Zhejiang HISUN Biomaterials Co. Ltd. A
Zhejiang Hisun Biomaterials Co.Ltd. engages in the research, development, production, and sale of polylactic acid in China. The company's products are used in various applications that include 3D printing, extrusion, thermoforming, film and laminating, injection molding, non-woven fabric, and injection blow molding. Zhejiang Hisun Biomaterials Co.Ltd. was founded in 2004 and is based in Taizhou, … Read more